BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36788227)

  • 1. Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.
    Jiang J; Chen HN; Jin P; Zhou L; Peng L; Huang Z; Qin S; Li B; Ming H; Luo M; Xie N; Gao W; Nice EC; Yu Q; Huang C
    Signal Transduct Target Ther; 2023 Feb; 8(1):65. PubMed ID: 36788227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs.
    Vikhanskaya F; Siddique MM; Kei Lee M; Broggini M; Sabapathy K
    Clin Cancer Res; 2005 Jun; 11(12):4348-56. PubMed ID: 15958617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p53 codon 72 Pro/Pro genotype identifies poor-prognosis neuroblastoma patients: correlation with reduced apoptosis and enhanced senescence by the p53-72P isoform.
    Cattelani S; Ferrari-Amorotti G; Galavotti S; Defferrari R; Tanno B; Cialfi S; Vergalli J; Fragliasso V; Guerzoni C; Manzotti G; Soliera AR; Menin C; Bertorelle R; McDowell HP; Inserra A; Belli ML; Varesio L; Tweddle D; Tonini GP; Altavista P; Dominici C; Raschellà G; Calabretta B
    Neoplasia; 2012 Jul; 14(7):634-43. PubMed ID: 22904680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of p53 codon 72 polymorphism with genetic susceptibility to hepatocellular carcinoma in Chinese population].
    Zhu ZZ; Cong WM; Zhu GS; Liu SF; Xian ZH; Wu WQ; Zhang XZ; Wang YH; Wu MC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):632-5. PubMed ID: 16331559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck.
    Andrade Filho PA; Ito D; Deleo AB; Ferris RL
    Cancer Immunol Immunother; 2010 Oct; 59(10):1561-8. PubMed ID: 20577877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α.
    Basu S; Gnanapradeepan K; Barnoud T; Kung CP; Tavecchio M; Scott J; Watters A; Chen Q; Kossenkov AV; Murphy ME
    Genes Dev; 2018 Feb; 32(3-4):230-243. PubMed ID: 29463573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein.
    Ozeki C; Sawai Y; Shibata T; Kohno T; Okamoto K; Yokota J; Tashiro F; Tanuma S; Sakai R; Kawase T; Kitabayashi I; Taya Y; Ohki R
    J Biol Chem; 2011 May; 286(20):18251-60. PubMed ID: 21454683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.
    Siddique M; Sabapathy K
    Oncogene; 2006 Jun; 25(25):3489-500. PubMed ID: 16462765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer.
    McGregor JM; Harwood CA; Brooks L; Fisher SA; Kelly DA; O'nions J; Young AR; Surentheran T; Breuer J; Millard TP; Lewis CM; Leigh IM; Storey A; Crook T
    J Invest Dermatol; 2002 Jul; 119(1):84-90. PubMed ID: 12164929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.
    Sullivan A; Syed N; Gasco M; Bergamaschi D; Trigiante G; Attard M; Hiller L; Farrell PJ; Smith P; Lu X; Crook T
    Oncogene; 2004 Apr; 23(19):3328-37. PubMed ID: 15077186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The codon 72 polymorphism-specific effects of human p53 are absent in mouse cells: implications on generation of mouse models.
    Phang BH; Sabapathy K
    Oncogene; 2007 May; 26(21):2964-74. PubMed ID: 17130838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective loss of phosphoserine aminotransferase 1 (PSAT1) suppresses migration, invasion, and experimental metastasis in triple negative breast cancer.
    Metcalf S; Dougherty S; Kruer T; Hasan N; Biyik-Sit R; Reynolds L; Clem BF
    Clin Exp Metastasis; 2020 Feb; 37(1):187-197. PubMed ID: 31630284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma.
    Ye J; Huang X; Tian S; Wang J; Wang H; Feng H; Zhao X; Cao S; Xuan Y; Li X; Ma X; Huang Y; Zhang X
    Exp Cell Res; 2024 Apr; 437(1):113977. PubMed ID: 38373588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter.
    Choi YS; Hong JM; Lim S; Ko KS; Pak YK
    Biochem Biophys Res Commun; 2006 Jun; 344(3):708-12. PubMed ID: 16631115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53
    Hernández-Reséndiz I; Gallardo-Pérez JC; López-Macay A; Robledo-Cadena DX; García-Villa E; Gariglio P; Saavedra E; Moreno-Sánchez R; Rodríguez-Enríquez S
    J Cell Physiol; 2019 May; 234(5):5524-5536. PubMed ID: 30272821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactate promotes metastasis of normoxic colorectal cancer stem cells through PGC-1α-mediated oxidative phosphorylation.
    Liu S; Zhao H; Hu Y; Yan C; Mi Y; Li X; Tao D; Qin J
    Cell Death Dis; 2022 Jul; 13(7):651. PubMed ID: 35896535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNPing away at mutant p53 activities.
    Ortiz GJ; Lozano G
    Genes Dev; 2018 Feb; 32(3-4):195-196. PubMed ID: 29491132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms.
    Popanda O; Edler L; Waas P; Schattenberg T; Butkiewicz D; Muley T; Dienemann H; Risch A; Bartsch H; Schmezer P
    Lung Cancer; 2007 Jan; 55(1):25-34. PubMed ID: 17059853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.